KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Capital Expenditures (2016 - 2026)

Evolent Health has reported Capital Expenditures over the past 11 years, most recently at $7.8 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 26.17% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $34.1 million, up 36.94%, while the annual FY2025 figure was $34.1 million, 36.94% up from the prior year.
  • Capital Expenditures for Q4 2025 was $7.8 million at Evolent Health, down from $9.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $10.7 million in Q4 2022 and troughed at $5.3 million in Q1 2024.
  • A 5-year average of $7.6 million and a median of $7.2 million in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: crashed 44.59% in 2021 and later skyrocketed 65.79% in 2022.
  • Year by year, Capital Expenditures stood at $7.2 million in 2021, then surged by 48.3% to $10.7 million in 2022, then tumbled by 43.67% to $6.1 million in 2023, then rose by 1.64% to $6.2 million in 2024, then increased by 26.17% to $7.8 million in 2025.
  • Business Quant data shows Capital Expenditures for EVH at $7.8 million in Q4 2025, $9.0 million in Q3 2025, and $8.8 million in Q2 2025.